Initiating high-efficacy monoclonal antibody therapy before age 18 may reduce long-term disability in pediatric-onset multiple sclerosis.
Applying for disability benefits is complicated. Blogger Trevis Gleason encourages people with multiple sclerosis to reach out to friends with MS for help with navigating the process.